Evidence map›Paper›PMID 32195280›Full record

ArticleIranian journal of biotechnology2019

Multi-functionPlantDefensin,AntimicrobialandHeavyMetal Adsorbent Peptide.

Neda Mirakhorli, Zahra Norolah, Samira Foruzandeh, Fateme Shafizade, Farzaneh Nikookhah, Behnaz Saffar, Omid Ansari

Open access · diamondAbstract read
In one paragraph

Article in Iranian journal of biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Neda MirakhorliDepartment of Plant Breeding and Biotechnology, Shahrekord University, Shahrekord, Iran.
Zahra NorolahDepartment of Plant Breeding and Biotechnology, Shahrekord University, Shahrekord, Iran.
Samira ForuzandehDepartment of Plant Breeding and Biotechnology, Shahrekord University, Shahrekord, Iran.
Fateme ShafizadeDepartment of Plant Breeding and Biotechnology, Shahrekord University, Shahrekord, Iran.
Farzaneh NikookhahDepartment of Fisheries and Environmental Science, Shahrekord University, Shahrekord, Iran.
Behnaz SaffarDepartment of Genetic, Shahrekord University, Shahrekord, Iran.
Omid AnsariEcofibre Industries Operations and Ananda Hemp, Brisbane, Australia.
Shahrekord University · IRReef Ecologic · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDefensin peptide isolated from plants are often heterogeneous in length, sequence and structure, but they are mostly small, cationic and amphipathic. Plant defensins exhibit broad-spectrum antibacterial and antifungal activities against Gram-positive and Gram-negative bacteria, fungi and etc. Plant defensins also play an important role in innate immunity, such as heavy metal and some abiotic stresses tolerance.

objectivesIn this paper, MATERIAL AND

methods

resultsWe confirmed the antibacterial activities of this peptide against Gram-negative (

resultsOut of six actinobacterial isolates, VITVAMB 1 possessed the most efficient RO-16 decolorization property. It decolorized 85.6% of RO-16 (250 mg L

conclusionsResults suggesting that modified defensin peptide facilitates a broader range of defense activities. dedefensins are an important part of the innate immune system in eukaryotes. These molecules have multidimensional properties that making them promising agents for therapeutic drugs.

Indexed as

Antibacterial EffectHeavy Metal AdsorptionPlant DefensinTherapeutic Potential

Identifiers

PMID32195280
PMCPMC7080970
OpenAlexW2980731113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.